Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...